The effects of oral zinc sulphate during radiotherapy on anti-oxidant enzyme activities in patients with head and neck cancer: a prospective, randomised, placebo-controlled study.

What Was Tested

Researchers studied Zinc Sulfate in this randomized controlled trial publication.

The purpose was to determine the effects of oral zinc sulphate along with radiotherapy on anti-oxidant enzyme activities in patients with head and neck cancer.

Why It Was Studied

Blood samples for biochemical parameters were collected after an overnight fast (12 h) before radiotherapy, the first day and 6 weeks after radiotherapy.

In the placebo group, three patients were excluded.

Who Took Part

The abstract describes 16 patients taking part.

PubMed indexes the participants as adults, middle-aged adults and older adults, both men and women.

How the Study Was Run

The researchers set it up as a randomized and placebo-controlled study.

Random assignment meant chance, not the researchers, decided who got Zinc Sulfate and who got the comparison, which limits bias.

The comparison arm used a placebo, so changes seen with Zinc Sulfate could be set against what happens without it.

What Was Measured

PubMed files the paper under topics including Antioxidants, Catalase, Combined Modality Therapy, Glutathione Peroxidase, Head and Neck Neoplasms, Oxidative Stress and Radiation Injuries.

What This Means in Plain Language

The paper is a randomized and placebo-controlled study of Zinc Sulfate in 16 patients.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

The publication is from 2004 (International journal of clinical practice), a journal based in United States.

More context: all human trials.